We are live on !
Find out more
David Shaw D.E. Shaw & Co
AUM
$210B
Turnover
26.1%
1-Year Est. Return
57.28%
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
This Fund
S&P 500
This Quarter Est. Return
+28.4%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.63%
5 Year Est. Return
+213.1%
10 Year Est. Return
+910%
AUM
$210B
AUM Growth
+$43.9B
(+26%)
Cap. Flow
+$8.31B
Cap. Flow % of AUM
Cap. Flow %
3.95%
Top 10 Holdings %
Top 10 Hldgs %
15.14%
Holding
5,360
New
872
Increased
1,718
Reduced
1,611
Closed
527
Avg Time Held
Equity + Options
2.6
years
Top 10 Avg Time Held
Equity + Options
0.4
years
Top 20 Avg Time Held
Equity + Options
1.2
years
Avg Time Held Equity only
2.6
years
Top 10 Avg Time Held Equity only
1.4
years
Top 20 Avg Time Held Equity only
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.6B |
| 2 |
Amazon
AMZN
|
+$1.56B |
| 3 |
NVIDIA
NVDA
|
+$1.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$924M |
| 5 |
SpaceX
SPCX
|
+$907M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.17B |
| 2 |
Broadcom
AVGO
|
+$1.53B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
TSMC
TSM
|
+$928M |
| 5 |
Texas Instruments
TXN
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 33.7% |
| 2 | Technology | 18.77% |
| 3 | Financials | 8.35% |
| 4 | Healthcare | 7.91% |
| 5 | Consumer Discretionary | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1426
Definium Therapeutics
DFTX
$5.12B
| $14.8M | 0.01% |
315,410
+43,693
| +16% | +$1.08M |
2025 Q1
5 quarters
|
|
1427
Prestige Consumer Healthcare
PBH
$2.26B
| $14.8M | 0.01% |
313,778
-67,255
| -18% | -$3.46M |
2018 Q4
30 quarters
|
|
1428
Bicara Therapeutics
BCAX
$646M
| $14.8M | 0.01% |
498,193
+221,250
| +80% | +$4.94M |
2025 Q4
2 quarters
|
|
1429
Chubb
CB
$137B
| $14.8M | 0.01% |
43,383
+37,394
| +624% | +$12.2M |
2021 Q4
18 quarters
|
|
1430
PUT
Humana
HUM
$49.5B
| $14.8M | 0.01% |
37,200
-62,700
| -63% | -$17.9M |
2023 Q4
10 quarters
|
|
1431
Star Bulk Carriers
SBLK
$3.35B
| $14.8M | 0.01% |
591,314
-582,563
| -50% | -$15.1M |
2025 Q4
2 quarters
|
|
1432
UGI
UGI
$8.25B
| $14.7M | 0.01% |
426,188
-81,945
| -16% | -$2.9M |
2026 Q1
1 quarter
|
|
1433
CALL
Dave Inc
DAVE
$4.12B
| $14.7M | 0.01% |
39,500
+29,300
| +287% | +$7.62M |
2025 Q2
4 quarters
|
|
1434
PUT
KKR & Co
KKR
$83.5B
| $14.7M | 0.01% |
160,100
+117,600
| +277% | +$11.4M |
2024 Q3
7 quarters
|
|
1435
Antero Midstream
AM
$9.8B
| $14.7M | 0.01% |
644,890
+230,024
| +55% | +$5M |
2021 Q4
18 quarters
|
|
1436
Burford Capital
BUR
$742M
| $14.7M | 0.01% |
3,577,247
+2,609,417
| +270% | +$11.9M |
2025 Q4
2 quarters
|
|
1437
Westlake Corp
WLK
$8.41B
| $14.6M | 0.01% |
200,534
-32,649
| -14% | -$3.19M |
2024 Q3
7 quarters
|
|
1438
Nutanix
NTNX
$19.7B
| $14.6M | 0.01% |
286,917
+259,283
| +938% | +$11.7M |
2021 Q1
21 quarters
|
|
1439
Lamar Advertising Co
LAMR
$15.8B
| $14.6M | 0.01% |
93,715
+86,285
| +1,161% | +$12.5M |
2024 Q4
6 quarters
|
|
1440
Idea Acquisition Corp
IACO
$437M
| $14.6M | 0.01% |
+1,472,601
| New | +$14.5M |
2026 Q2
0 quarters
|
|
1441
Orion
OEC
$309M
| $14.5M | 0.01% |
2,194,308
-282,485
| -11% | -$2.03M |
2022 Q4
14 quarters
|
|
1442
Affiliated Managers Group
AMG
$10.2B
| $14.5M | 0.01% |
42,839
+3,578
| +9% | +$1.11M |
2016 Q2
40 quarters
|
|
1443
Wheaton Precious Metals
WPM
$57.5B
| $14.5M | 0.01% |
129,019
+115,767
| +874% | +$15.1M |
2024 Q3
7 quarters
|
|
1444
Hello Group
MOMO
$642M
| $14.5M | 0.01% |
2,496,180
-79,829
| -3% | -$476K |
2024 Q3
7 quarters
|
|
1445
Colgate-Palmolive
CL
$73.1B
| $14.5M | 0.01% |
157,872
-321,478
| -67% | -$28.1M |
2014 Q3
47 quarters
|
|
1446
ANI Pharmaceuticals
ANIP
$1.65B
| $14.5M | 0.01% |
174,732
-38,701
| -18% | -$3.1M |
2024 Q2
8 quarters
|
|
|
BCAR
1447
DELISTED
D. Boral ARC Acquisition I Corp
BCAR
| $14.5M | 0.01% |
1,385,950
| – | – |
2025 Q3
3 quarters
|
|
1448
Assured Guaranty
AGO
$3.05B
| $14.4M | 0.01% |
180,107
+48,148
| +36% | +$3.8M |
2022 Q1
17 quarters
|
|
1449
Church & Dwight Co
CHD
$24.8B
| $14.4M | 0.01% |
148,791
-611,921
| -80% | -$58.5M |
2020 Q4
22 quarters
|
|
1450
CALL
eToro Group
ETOR
$1.88B
| $14.4M | 0.01% |
365,200
+130,200
| +55% | +$4.9M |
2026 Q1
1 quarter
|
|
Similar funds
David Shaw's Q2 2026 Portfolio in Review
As of Q2 2026, David Shaw held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
David Shaw deployed $8.31B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.
By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.
- David Shaw's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.6B increase.
- David Shaw's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
- David Shaw fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
- David Shaw's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
- David Shaw opened 872 new positions and closed 527 in Q2 2026.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $210B.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.